Skip to main content

PERSPECTIVE article

Front. Cell Dev. Biol.
Sec. Stem Cell Research
Volume 12 - 2024 | doi: 10.3389/fcell.2024.1368171

Emerging role of HDAC11 in skeletal muscle biology Provisionally Accepted

 Qiao Li1* Jihong Chen2
  • 1Cellular and Molecular Medicine, University of Ottawa, Canada
  • 2University of Ottawa, Canada

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

HDAC11 is an epigenetic repressor of gene transcription, acting through its deacetylase activity to remove functional acetyl groups from the lysine residues of histones at genomic loci. It has been implicated in the regulation of different immune responses, metabolic activities, as well as cell cycle progression. Recent studies have also shed lights on the impact of HDAC11 on myogenic differentiation and muscle development, indicating that HDAC11 is important for histone deacetylation at the promoters to inhibit transcription of cell cycle related genes, thereby permitting myogenic activation at the onset of myoblast differentiation. Interestingly, the upstream networks of HDAC11 target genes are mainly associated with cell cycle regulators and the acetylation of histones at the HDAC11 target promoters appears to be residue specific. As such, selective inhibition, or activation of HDAC11 presents a potential therapeutic approach for targeting distinct epigenetic pathways in clinic applications.

Keywords: histone acetylation, Histone deacetylase, gene regulation, chromatin modification, Myogenic Differentiation

Received: 10 Jan 2024; Accepted: 07 May 2024.

Copyright: © 2024 Li and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Qiao Li, University of Ottawa, Cellular and Molecular Medicine, Ottawa, K1H 8M5, Ontario, Canada